Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-enhanced Curcumin for Maintenance of Remission in Ulcerative Colitis
NCT02683759Phase 3Unknown
- Sponsor
- Asian Institute of Gastroenterology
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of curcumin in ulcerative colitis (UC), sponsored by Asian Institute of Gastroenterology. Status: unknown.
02
Drugs
curcumin
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT02683759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683759.